Kymera Therapeutics, Inc. (KYMR)
Total Valuation
KYMR has a market cap or net worth of $1.04 billion. The enterprise value is $631.76 million.
Market Cap | 1.04B |
Enterprise Value | 631.76M |
Important Dates
The next earnings date is Friday, August 5, 2022, before market open.
Estimated Earnings Date | Aug 5, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
KYMR has 51.72 million shares outstanding. The number of shares has increased by 15.68% in one year.
Shares Outstanding | 51.72M |
Shares Change (YoY) | +15.68% |
Shares Change (QoQ) | +0.43% |
Owned by Insiders (%) | 8.29% |
Owned by Institutions (%) | 92.48% |
Float | 34.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.43 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.04.
Current Ratio | 4.88 |
Quick Ratio | 4.83 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -30.40%, which is considered low. The company has a ROIC of -31.00%.
Return on Equity (ROE) | -30.40% |
Return on Assets (ROA) | -22.10% |
Return on Capital (ROIC) | -31.00% |
Revenue Per Employee | n/a |
Profits Per Employee | -$865,916 |
Employee Count | 143 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.30% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -55.30% |
50-Day Moving Average | 15.93 |
200-Day Moving Average | 36.25 |
Average Volume (30 Days) | 754,556 |
Short Selling Information
The latest short interest is 4.92 million, so 9.51% of the outstanding shares have been sold short.
Short Interest | 4.92M |
Short % of Shares Out | 9.51% |
Short % of Float | 14.34% |
Short Ratio (days to cover) | 4.74 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -188.05M |
Net Income | -123.83M |
EBITDA | -121.04M |
EBIT | -123.64M |
Earnings Per Share (EPS) | -$2.49 |
Balance Sheet
The company has $426.92 million in cash and $17.47 million in debt, giving a net cash position of $409.45 million or $7.92 per share.
Cash & Cash Equivalents | 426.92M |
Total Debt | 17.47M |
Net Cash | 409.45M |
Net Cash Per Share | $7.92 |
Book Value | 428.72M |
Book Value Per Share | 8.29 |
Working Capital | 343.04M |
Cash Flow
In the last 12 months, operating cash flow was -$146.42 million and capital expenditures -$1.92 million, giving a free cash flow of -$148.33 million.
Operating Cash Flow | -146.42M |
Capital Expenditures | -1.92M |
Free Cash Flow | -148.33M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -11.89% |
FCF Yield | -14.25% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.68% |
Shareholder Yield | -15.68% |
Analyst Forecast
The average price target for KYMR is $64.34, which is 219.62% higher than the current price. The consensus rating is "Buy".
Price Target | $64.34 |
Price Target Difference | 219.62% |
Analyst Consensus | Buy |
Analyst Count | 20 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |